To boost diversity in clinical trials, NIH takes to the road to collect DNA from underrepresented groups

Aug 9, 2022
During the pandemic, the effort suspended in-person recruiting and lost momentum.
The All of Us bus helps the program connect with potential drug trial participants and collect biospecimens.
Blake Farmer/WPLN News

Inside CureVac's odyssey to produce a COVID-19 vaccine

Oct 1, 2021
CureVac finds itself playing catch-up with other companies in producing a COVID vaccine, but the company refuses to give up.
General view outside the company of German vaccine maker CureVac on September 1, 2020 in Tubingen, Germany.
Christian Kaspar-Bartke/Getty Images